Clinical factors such as tumor stage, tumor necrosis, vascular invasion, differentiation, Ki67, serum CEA, and inflammation have been reported to influence the prognosis of CRC patients (2–5). The gene discussed is CEACAM5; the disease is colorectal carcinoma.